A new preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR ...

There is no current treatment for PVR other than surgery, which itself carries ... and preclinical models of proliferative vitreoretinopathy and abnormal blood vessel growth to show that mRNA ...